Aurinia Pharmaceuticals
AUPH
AUPH
200 hedge funds and large institutions have $487M invested in Aurinia Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 65 increasing their positions, 50 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.24% less ownership
Funds ownership: 35.43% → 35.19% (-0.24%)
12% less capital invested
Capital invested by funds: $553M → $487M (-$66M)
Holders
200
Holding in Top 10
1
Calls
$22.5M
Puts
$20.8M
Top Buyers
| 1 | +$7.83M | |
| 2 | +$6.69M | |
| 3 | +$5.82M | |
| 4 |
JGC
J. Goldman & Co
New York
|
+$5.73M |
| 5 |
AC
Armistice Capital
New York
|
+$5.4M |
Top Sellers
| 1 | -$21.6M | |
| 2 | -$14.5M | |
| 3 | -$10M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$5.26M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$4.71M |